APA (7th ed.) Citation

JE, L. L., Q, D., MB, M., N, B., BT, H., J, F., . . . JS, G. (2021). Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial. Science translational medicine, 13(590), . https://doi.org/10.1126/scitranslmed.abb0602

Chicago Style (17th ed.) Citation

JE, Le Lay, et al. "Blocking Endothelial Lipase with Monoclonal Antibody MEDI5884 Durably Increases High Density Lipoprotein in Nonhuman Primates and in a Phase 1 Trial." Science Translational Medicine 13, no. 590 (2021). https://doi.org/10.1126/scitranslmed.abb0602.

MLA (9th ed.) Citation

JE, Le Lay, et al. "Blocking Endothelial Lipase with Monoclonal Antibody MEDI5884 Durably Increases High Density Lipoprotein in Nonhuman Primates and in a Phase 1 Trial." Science Translational Medicine, vol. 13, no. 590, 2021, https://doi.org/10.1126/scitranslmed.abb0602.